Breaking News Instant updates and real-time market news.

ASLN

Aslan Pharmaceuticals

$1.73

(0.00%)

11:38
09/30/19
09/30
11:38
09/30/19
11:38

Piper Jaffray backs Overweight rating on Aslan Pharma after JV creation

Piper Jaffray analyst Edward Tenthoff reiterated an Overweight rating and $7 price target on Aslan Pharmaceuticals after the company announced the creation of a joint venture with Bukwang Pharmaceuticals to develop novel immuno-oncology therapies, in which Aslan will contribute preclinical aryl hydrocarbon receptor antagonists. In a research note to investors, Tenhoff says he believes the JV is an "innovative" way to develop preclinical assets and further validation of Aslan's discovery capabilities.

ASLN Aslan Pharmaceuticals
$1.73

(0.00%)

01/14/19
HCWC
01/14/19
NO CHANGE
Target $8.5
HCWC
Buy
Aslan Pharmaceuticals price target lowered to $8.50 from $12 at H.C. Wainwright
H.C. Wainwright analyst Raghuram Selvaraju lowered his price target for Aslan Pharmaceuticals to $8.50 after varlitinib data in first-line gastric cancer didn't show statistical significance. The analyst, however, reiterates a Buy rating on the shares.
01/15/19
PIPR
01/15/19
NO CHANGE
Target $7
PIPR
Overweight
Aslan achieved 'impressive' overall response rate in BTC, says Piper Jaffray
Aslan Pharmaceuticals' varlitinib added to gemcitabine and cisplatine achieved an "impressive" overall response rate of 43.8% and disease control rate of 93.8% in the Phase Ib/II study in first-line biliary tract cancer, Piper Jaffray analyst Edward Tenthoff tells investors in a research note. Varlitinib was also well tolerated with the most common adverse events decreases in platelet and neutrophil counts, adds the analyst. The data presented last night increase his confidence in the fully-enrolled Phase III TreeTopp trial of varlitinib in second line biliary tract cancer with top-line data in the second half of 2019. He reiterates an Overweight rating on Aslan Pharmaceuticals with a $7 price target.
01/30/19
PIPR
01/30/19
NO CHANGE
Target $7
PIPR
Overweight
Piper Jaffray reiterates Overweight rating on Aslan after restructuring news
After Aslan Pharmaceuticals announced it is conducting a corporate restructuring that will cut headcount by 30% and operating costs by 50%, Piper Jaffray analyst Edward Tenthoff noted the restructuring does not impact development of wholly-owned varlitinib in biliary tract cancer, ASLAN003 in acute myeloid leukemia and ASLAN004 in atopic dermatitis. Tenthoff, who said the primary driver for varlitinib remains Phase 3 TreeTopp trial data in the second half of 2019, reiterates an Overweight rating and $7 price target on Aslan shares.
04/01/19
PIPR
04/01/19
NO CHANGE
Target $7
PIPR
Overweight
Aslan data show comparable activity to Dupixent, says Piper Jaffray
Aslan Pharmaceuticals reported preliminary Phase I single-ascending dose data on intravenous ASLAN004 demonstrating the IL13 receptor antibody to be safe and well tolerated in healthy volunteers with no discontinuations due to adverse events, Piper Jaffray analyst Edward Tenthoff tells investors in a research note. ASLAN004 caused complete inhibition of phosphorylation of STAT6 within one hour lasting for greater than 29 days, adds the analyst. He believes these results present the opportunity for once-monthly dosing of ASLAN004 with comparable activity to Regeneron's (REGN) Dupixent. Tenthoff reiterates an Overweight rating on Aslan Pharmaceuticals with a $7 price target.

TODAY'S FREE FLY STORIES

PYPL

PayPal

$102.07

-0.61 (-0.59%)

, FB

Facebook

$194.47

4.9 (2.58%)

18:22
11/12/19
11/12
18:22
11/12/19
18:22
Hot Stocks
PayPal CFO: We are a better company, stronger workforce with veterans »

In an interview on…

PYPL

PayPal

$102.07

-0.61 (-0.59%)

FB

Facebook

$194.47

4.9 (2.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 10

    Dec

EADSY

Airbus

$0.00

(0.00%)

, AFLYY

Air France-KLM

$0.00

(0.00%)

18:22
11/12/19
11/12
18:22
11/12/19
18:22
Periodicals
Airbus says could stretch A220 jet to carry more passengers, Reuters says »

Philippe Balducchi, head…

EADSY

Airbus

$0.00

(0.00%)

AFLYY

Air France-KLM

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CCNE

CNB Financial

$33.10

-0.23 (-0.69%)

18:21
11/12/19
11/12
18:21
11/12/19
18:21
Syndicate
CNB Financial offering up to $40M in 'at-the-market' common stock »

The shares will be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$362.89

-4.08 (-1.11%)

, ALK

Alaska Air

$70.87

-1.015 (-1.41%)

18:18
11/12/19
11/12
18:18
11/12/19
18:18
Periodicals
U.S. carriers willing to take 737 jets before training clearance, Reuters says »

Certain U.S. airline…

BA

Boeing

$362.89

-4.08 (-1.11%)

ALK

Alaska Air

$70.87

-1.015 (-1.41%)

LUV

Southwest

$57.87

-0.4 (-0.69%)

DAL

Delta Air Lines

$57.23

(0.00%)

JBLU

JetBlue

$19.31

-0.44 (-2.23%)

UAL

United Airlines

$92.73

-0.77 (-0.82%)

SAVE

Spirit Airlines

$37.86

-0.9 (-2.32%)

AAL

American Airlines

$29.51

-1.08 (-3.53%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 12

    Nov

  • 13

    Nov

  • 13

    Nov

  • 14

    Nov

  • 14

    Nov

  • 12

    Dec

  • 23

    Jan

PBR

Petrobras

$15.65

-0.146 (-0.92%)

18:15
11/12/19
11/12
18:15
11/12/19
18:15
Hot Stocks
Petrobras discloses teaser for sale of assets in Uruguay »

Brazil's Petrobras…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

YY

YY

$65.12

-0.28 (-0.43%)

18:05
11/12/19
11/12
18:05
11/12/19
18:05
Hot Stocks
YY reports Q3 global average mobile MAUs 470.1M from 433.5M in Q2 »

Q3 Average mobile MAUs of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

HUYA

Huya

$24.28

-1.05 (-4.15%)

18:04
11/12/19
11/12
18:04
11/12/19
18:04
Hot Stocks
Huya sees Q4 revenue up 55.5%-60.8% YoY »

Sees Q4 total net…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 09

    Dec

YY

YY

$65.12

-0.28 (-0.43%)

18:03
11/12/19
11/12
18:03
11/12/19
18:03
Earnings
Breaking Earnings news story on YY »

YY sees Q4 revenue up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

HUYA

Huya

$24.28

-1.05 (-4.15%)

18:03
11/12/19
11/12
18:03
11/12/19
18:03
Earnings
Huya reports Q3 EPS 7c, consensus 11c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 09

    Dec

YY

YY

$65.12

-0.28 (-0.43%)

18:01
11/12/19
11/12
18:01
11/12/19
18:01
Earnings
YY reports Q3 adjusted EPS 90c, consensus 80c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

LAZ

Lazard

$38.51

-0.03 (-0.08%)

18:00
11/12/19
11/12
18:00
11/12/19
18:00
Hot Stocks
Lazard CAO sells 40,000 class A common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$362.89

-4.08 (-1.11%)

17:53
11/12/19
11/12
17:53
11/12/19
17:53
Periodicals
Boeing moves pilot to new job following leaked messages, Reuters says »

One of two Boeing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

AVYA

Avaya

$12.53

0.08 (0.64%)

, RNG

RingCentral

$172.89

2.57 (1.51%)

17:45
11/12/19
11/12
17:45
11/12/19
17:45
Syndicate
Avaya files to sell 1.75M shares of RingCentral Class A common stock »

Avaya Holdings (AVYA)…

AVYA

Avaya

$12.53

0.08 (0.64%)

RNG

RingCentral

$172.89

2.57 (1.51%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 13

    Nov

  • 13

    Nov

  • 20

    Nov

  • 09

    Dec

17:45
11/12/19
11/12
17:45
11/12/19
17:45
General news
Breaking General news story  »

Minneapolis Federal…

NVTR

Nuvectra

$1.41

0.085 (6.44%)

17:37
11/12/19
11/12
17:37
11/12/19
17:37
Hot Stocks
Nuvectra to file voluntary petition for reorganization under Chapter 11 »

Nuvectra announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XELB

Xcel Brands

$1.60

(0.00%)

17:34
11/12/19
11/12
17:34
11/12/19
17:34
Hot Stocks
Xcel Brands, Hilco Global acquire intellectual property of Longaberger »

Xcel Brands and Hilco…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

PSNL

Personalis

$10.17

-0.55 (-5.13%)

17:32
11/12/19
11/12
17:32
11/12/19
17:32
Hot Stocks
Personalis expands oncology portfolio, launching cancer genome sequence service »

Personalis announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 19

    Nov

  • 20

    Nov

KTB

Kontoor Brands

$36.07

0.06 (0.17%)

17:28
11/12/19
11/12
17:28
11/12/19
17:28
Initiation
Kontoor Brands initiated  »

Kontoor Brands initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HBI

Hanesbrands

$15.63

-0.355 (-2.22%)

17:25
11/12/19
11/12
17:25
11/12/19
17:25
Initiation
Hanesbrands initiated  »

Hanesbrands initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRQ

Turquoise Hill

$0.47

0.0049 (1.06%)

17:24
11/12/19
11/12
17:24
11/12/19
17:24
Earnings
Turquoise Hill reports Q3 EPS 4c, consensus 0c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

GPS

Gap

$17.16

0.06 (0.35%)

17:23
11/12/19
11/12
17:23
11/12/19
17:23
Initiation
Gap initiated  »

Gap initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

ADP

ADP

$166.40

3.04 (1.86%)

17:22
11/12/19
11/12
17:22
11/12/19
17:22
Hot Stocks
ADP announces $5B share repurchase program »

The board of directors of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

KNSL

Kinsale Capital Group

$88.98

1.78 (2.04%)

, DF

Dean Foods

$0.79

(0.00%)

17:18
11/12/19
11/12
17:18
11/12/19
17:18
Hot Stocks
Kinsale Capital Group to replace Dean Foods in S&P 600 at open on 11/18 »

Dean Foods announced that…

KNSL

Kinsale Capital Group

$88.98

1.78 (2.04%)

DF

Dean Foods

$0.79

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Dec

  • 04

    Dec

GIII

G-III Apparel

$28.51

-0.35 (-1.21%)

17:17
11/12/19
11/12
17:17
11/12/19
17:17
Initiation
G-III Apparel initiated  »

G-III Apparel initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SGEN

Seattle Genetics

$110.62

2.44 (2.26%)

17:17
11/12/19
11/12
17:17
11/12/19
17:17
Hot Stocks
Seattle Genetics submits arbitration demand against Daiichi Sankyo »

Seattle Genetics, Inc.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 15

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.